News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
490,474 Results
Type
Article (9233)
Company Profile (142)
Press Release (480828)
Multimedia
Podcasts (10)
Webinars (7)
Section
Business (168068)
Career Advice (355)
Deals (25890)
Drug Delivery (14)
Drug Development (53815)
Employer Resources (26)
FDA (10022)
Job Trends (8821)
News (240523)
Policy (18185)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (516)
Accelerated approval (29)
ADA (21)
Adcomms (1)
Allergies (104)
Alliances (33527)
ALS (114)
Alzheimer's disease (1033)
Antibody-drug conjugate (ADC) (296)
Approvals (10692)
Artificial intelligence (355)
ASCO (168)
Autoimmune disease (241)
Automation (31)
Bankruptcy (264)
Belgium (1)
Best Places to Work (7119)
BIO (38)
Biologics (10)
BIOSECURE Act (1)
Biosimilars (121)
BioSpace Insights (17)
Biotechnology (91)
Bispecific (1)
Bladder cancer (143)
Brain cancer (36)
Breast cancer (572)
Cancer (3953)
Cardiovascular disease (234)
Career advice (292)
Career pathing (1)
CAR-T (181)
CDC (1)
CDMO (24)
Celiac Disease (1)
Cell therapy (499)
Cervical cancer (37)
Clinical research (48896)
Collaboration (1328)
Commercialization (3)
Compensation (1538)
Complete response letters (37)
COVID-19 (820)
CRISPR (64)
C-suite (849)
Cystic fibrosis (88)
Data (6036)
Denatured (4)
Depression (107)
Dermatology (71)
Diabetes (374)
Diagnostics (4298)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (7)
Drug discovery (169)
Drug pricing (13)
Drug shortages (2)
Duchenne muscular dystrophy (169)
Earnings (73948)
Editorial (3)
Employer branding (8)
Employer resources (25)
Events (88557)
Executive appointments (738)
FDA (12853)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (979)
Gene editing (126)
Generative AI (14)
Gene therapy (339)
GLP-1 (321)
Government (1008)
Grass and pollen (2)
Guidances (282)
Healthcare (9432)
Hematology (101)
HIV (57)
Huntington's disease (24)
IgA nephropathy (73)
Immunology and inflammation (120)
Immuno-oncology (65)
Indications (164)
Infectious disease (1017)
Inflammatory bowel disease (133)
Inflation Reduction Act (5)
Influenza (90)
Intellectual property (266)
Interviews (53)
IPO (12441)
IRA (4)
Job creations (2047)
Job search strategy (276)
JPM (2)
Kidney cancer (17)
Kidney disease (46)
Labor market (5)
Layoffs (96)
Leadership (1)
Legal (5250)
Licensing (21)
Liver cancer (53)
Longevity (19)
Lung cancer (565)
Lymphoma (296)
Machine learning (29)
Management (6)
Manufacturing (602)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8692)
Medtech (8852)
Mergers & acquisitions (14511)
Metabolic disorders (766)
mRNA (76)
Multiple sclerosis (128)
NASH (4)
Neurodegenerative disease (239)
Neuropsychiatric disorders (41)
Neuroscience (1959)
NextGen: Class of 2026 (3233)
Non-profit (874)
Now hiring (2)
Obesity (254)
Opinion (33)
Ovarian cancer (166)
Pain (179)
Pancreatic cancer (209)
Parkinson's disease (214)
Partnered (12)
Patents (507)
Patient recruitment (537)
Patient selection (4)
Peanut (35)
People (41908)
Peptides (3)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15732)
Phase 2 (21778)
Phase 3 (15012)
Pipeline (7905)
Policy (26)
Postmarket research (1595)
Preclinical (6605)
Press Release (34)
Prostate cancer (195)
Psychedelics (9)
Radiopharmaceuticals (197)
Rare diseases (604)
Real estate (3066)
Recruiting (10)
Regenerative medicine (2)
Regulatory (15279)
Reports (25)
Research institute (611)
Resumes & cover letters (49)
Rett syndrome (42)
RNA editing (5)
RSV (50)
Schizophrenia (104)
Series A (170)
Series B (129)
Service/supplier (5)
Sickle cell disease (63)
Special edition (2)
Spinal muscular atrophy (120)
Sponsored (6)
Startups (2093)
Stomach cancer (6)
Substance use disorders (16)
Supply chain (52)
Tariffs (1)
The Weekly (6)
Vaccines (338)
Venture capital (22)
Weight loss (84)
Women's health (90)
Date
Today (62)
Last 7 days (304)
Last 30 days (1525)
Last 365 days (19405)
2026 (14095)
2025 (19515)
2024 (23205)
2023 (26757)
2022 (34915)
2021 (37458)
2020 (33747)
2019 (23612)
2018 (17793)
2017 (19008)
2016 (18180)
2015 (24480)
2014 (21811)
2013 (18268)
2012 (20347)
2011 (20566)
2010 (20411)
Location
Africa (270)
Alabama (80)
Alaska (2)
Arizona (321)
Arkansas (11)
Asia (18315)
Australia (2274)
California (12551)
Canada (3268)
China (555)
Colorado (505)
Connecticut (428)
Delaware (217)
Europe (25952)
Florida (1869)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (743)
India (52)
Indiana (343)
Iowa (16)
Japan (434)
Kansas (104)
Kentucky (34)
Louisiana (27)
Maine (26)
Maryland (1235)
Massachusetts (8161)
Michigan (315)
Minnesota (574)
Mississippi (4)
Missouri (83)
Montana (20)
Nebraska (11)
Nevada (125)
New Hampshire (60)
New Jersey (2727)
New Mexico (12)
New York (2918)
North Carolina (1334)
North Dakota (4)
Northern California (6361)
Ohio (297)
Oklahoma (14)
Oregon (17)
Pennsylvania (2309)
Puerto Rico (23)
Rhode Island (30)
South America (443)
South Carolina (78)
South Dakota (1)
Southern California (5183)
Tennessee (125)
Texas (2030)
United States (40485)
Utah (378)
Vermont (1)
Virginia (160)
Washington D.C. (39)
Washington State (963)
West Virginia (1)
Wisconsin (76)
Wyoming (1)
490,474 Results for "genentech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Antibody-drug conjugate (ADC)
Genentech strikes second Asia deal in a week, betting up to $1B in oncology ADC alliance with DualityBio
Through its DualityBio deal, Roche’s Genentech hopes to create antibody-drug conjugates with payloads that can circumvent growing cancer drug resistance.
August 28, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Ark Clinical Research Joins Genentech’s Advancing Inclusive Research® Site Alliance
September 3, 2026
·
2 min read
Press Releases
Positive Interim Data Shows Genentech’s Sefaxersen Significantly Reduces Proteinuria in People With IgA Nephropathy (IgAN)
September 23, 2026
·
6 min read
Business
Genentech culls 103 jobs, inks $490M-plus biobucks deal with Astex
With the latest round, Roche’s Genentech will have racked up nearly 450 layoffs in California over the last year amid ongoing restructuring. At the same time, the biotech is joining forces with Astex Pharmaceuticals in a deal that could surpass $490 million.
July 6, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Genentech’s Lunsumio-Based Regimen Significantly Improves Progression-Free Survival in Follicular Lymphoma in Phase III CELESTIMO Study
September 17, 2026
·
15 min read
Press Releases
U.S. FDA Grants Priority Review for Genentech’s Enspryng for MOGAD, an Autoimmune Disease With No Approved Treatments
September 10, 2026
·
11 min read
Layoffs
Genentech R&D layoffs hit top exec who’s been with the biotech nearly 30 years
The staffing changes will focus resources on work that creates the highest impact for patients, according to Genentech. The number of employees affected is unknown, but longtime veteran Vishva Dixit is out.
June 11, 2026
·
1 min read
·
Angela Gabriel
Press Releases
Genentech Announces Manufacturing Expansion in Hillsboro, Oregon
August 20, 2026
·
4 min read
Press Releases
Genentech and Roche Announce Grand Opening of Boston R&D Innovation Center
September 17, 2026
·
4 min read
Press Releases
FDA Grants Priority Review to Genentech’s Gazyva for Adults With Primary Membranous Nephropathy
July 15, 2026
·
13 min read
1 of 49,048
Next
